BACKGROUND: Anti-dengue virus (DENV) immunoglobulin M (IgM) seroconversion has been the reference standard for dengue diagnosis. However, paired specimens are rarely obtained, and the interval for this testing negates its usefulness in guiding clinical case management. The presence of DENV viremia and appearance of IgM during the febrile phase of dengue provides the framework for dengue laboratory diagnosis by using a single serum specimen. METHODS: Archived paired serum specimens (n = 1234) from patients with laboratory-confirmed dengue from 2005 through 2011 were used to determine the diagnostic performance of real-time reverse transcription polymerase chain reaction (RT-PCR), for detection of DENV serotypes 1-4, and enzyme-linked immunosorbent assays (ELISAs), for detection of DENV nonstructural protein 1 (NS1) antigen and anti-DENV IgM. RESULTS: During 1-3 days after illness onset, real-time RT-PCR and NS1 antigen testing detected 82%-69% and 90%-84% of cases, respectively, as viremia levels declined, while anti-DENV IgM ELISA detected 5%-41% of cases as antibody appeared. Over the 10-day period of the febrile phase of dengue, the cumulative effect of using these 3 types of tests in a diagnostic algorithm confirmed ≥90% of dengue cases. CONCLUSIONS: The use of molecular or NS1 antigen tests to detect DENV and one to detect anti-DENV IgM in a single serum specimen collected during the first 10 days of illness accurately identified ≥90% of dengue primary and secondary cases. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: Anti-dengue virus (DENV) immunoglobulin M (IgM) seroconversion has been the reference standard for dengue diagnosis. However, paired specimens are rarely obtained, and the interval for this testing negates its usefulness in guiding clinical case management. The presence of DENV viremia and appearance of IgM during the febrile phase of dengue provides the framework for dengue laboratory diagnosis by using a single serum specimen. METHODS: Archived paired serum specimens (n = 1234) from patients with laboratory-confirmed dengue from 2005 through 2011 were used to determine the diagnostic performance of real-time reverse transcription polymerase chain reaction (RT-PCR), for detection of DENV serotypes 1-4, and enzyme-linked immunosorbent assays (ELISAs), for detection of DENV nonstructural protein 1 (NS1) antigen and anti-DENV IgM. RESULTS: During 1-3 days after illness onset, real-time RT-PCR and NS1 antigen testing detected 82%-69% and 90%-84% of cases, respectively, as viremia levels declined, while anti-DENV IgM ELISA detected 5%-41% of cases as antibody appeared. Over the 10-day period of the febrile phase of dengue, the cumulative effect of using these 3 types of tests in a diagnostic algorithm confirmed ≥90% of dengue cases. CONCLUSIONS: The use of molecular or NS1 antigen tests to detect DENV and one to detect anti-DENV IgM in a single serum specimen collected during the first 10 days of illness accurately identified ≥90% of dengue primary and secondary cases. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Gabriela Paz-Bailey; Eli S Rosenberg; Kate Doyle; Jorge Munoz-Jordan; Gilberto A Santiago; Liore Klein; Janice Perez-Padilla; Freddy A Medina; Stephen H Waterman; Carlos Garcia Gubern; Luisa I Alvarado; Tyler M Sharp Journal: N Engl J Med Date: 2017-02-14 Impact factor: 91.245
Authors: Laura E Adams; Liliana Sánchez-González; Dania M Rodriguez; Kyle Ryff; Chelsea Major; Olga Lorenzi; Mark Delorey; Freddy A Medina; Jorge L Muñoz-Jordán; Grayson Brown; Marianyoly Ortiz; Stephen H Waterman; Vanessa Rivera-Amill; Gabriela Paz-Bailey Journal: PLoS Negl Trop Dis Date: 2022-06-13
Authors: Alastair I Matheson; Ondari D Mogeni; Joshua R Lacsina; Melvin Ochieng; Allan Audi; Godfrey Bigogo; John Neatherlin; Harold S Margolis; Barry Fields; Petronella Ahenda; Judd L Walson; Joel M Montgomery Journal: Am J Trop Med Hyg Date: 2020-11 Impact factor: 2.345
Authors: Ralph Huits; Patrick Soentjens; Ula Maniewski-Kelner; Caroline Theunissen; Steven Van Den Broucke; Eric Florence; Jan Clerinx; Erika Vlieghe; Jan Jacobs; Lieselotte Cnops; Dorien Van Den Bossche; Marjan Van Esbroeck; Emmanuel Bottieau Journal: Open Forum Infect Dis Date: 2017-01-09 Impact factor: 3.835
Authors: Elizabeth A Hunsperger; Claudia N Duarte Dos Santos; Huong Thi Que Vu; Sutee Yoksan; Vincent Deubel Journal: PLoS Negl Trop Dis Date: 2017-09-07